Bright Green Corp

Bright Green Corp. engages in the cultivation, manufacture, and sale of medical cannabis. It focuses on the research and development of cannabis strains and sales of products with cannabinol (CBN) and cannabigerol (CBG). The company was founded by Lynn Stockwell on April 16, 2019 and is headquartered in Fort Lauderdale, FL.

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Bright Green Corp. engages in the cultivation, manufacture, and sale of medical cannabis. It focuses on the research and development of cannabis strains and sales of products with cannabinol and cannabigerol. The company was founded by Lynn Stockwell on April 16, 2019 and is headquartered in Grants, NM.

Bright Green is now the first publicly traded company, and the largest, in the U.S. to be federally authorized to grow, manufacture and sell cannabis and cannabis-related products for research, pharmaceutical applications and affiliated import and export

Bright Green Announces Historic Federal Registration and License Approval from the U.S. Drug Enforcement Administration Confirming Bright Green as a Bulk Manufacturer of Cannabis

Continued investment to support long-term strategy and pathway for growth, including plans to fully acquire Alterola Biotech, appointment of Seamus McAuley as Chief Executive Officer and expansion of Scientific Advisory Board

Bright Green Announces Fourth Quarter 2022 Financial Update

Bright Green to acquire remaining 75% of Alterola common stock

Bright Green Announces Decision to Complete Alterola Biotech Acquisition

Chembio Diagnostics

Healthcare Triangle

Hepion Pharmaceuticals Inc

Hillstream Biopharma

Magenta Therapeutics Inc

Sigilon Therapeutics

Spectrum Pharma

The healthcare sector has more high return generating companies than many other sectors.

10 Best-Performing Penny Stocks in the Health Care Sector

NEW YORK , March 30, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Bright Green Corporation (NASDAQ: BGXX) resulting from allegations that Bright Green may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Bright Green securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

BGXX LOSS ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM , Encourages Bright Green Corporation Investors to Inquire About Class Action Investigation - BGXX

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Bright Green Corporation (“Bright Green” or the “Company”) (NASDAQ: BGXX) investors concerning the Company's possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Bright Green Corporation (BGXX) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Bright Green Corporation (“Bright Green” or the “Company”) (NASDAQ: BGXX) investors concerning the Company's possible violations of federal securities laws. On June 2, 2022, Green Market Report published a report alleging that Bright Green's former CEO was accusing the Company of fraud, claiming Bright Green was a “sham, operated illegally and fraudulently.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Bright Green Corporation (BGXX) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Bright Green Corporation (“Bright Green” or the “Company”) (NASDAQ: BGXX) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate.

The Law Offices of Frank R. Cruz Announces Investigation of Bright Green Corporation (BGXX) on Behalf of Investors

NEW YORK , March 10, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Bright Green Corporation (NASDAQ: BGXX) resulting from allegations that Bright Green may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Bright Green securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

TOP RANKED ROSEN LAW FIRM Encourages Bright Green Corporation Investors to Inquire About Class Action Investigation - BGXX

NEW YORK , March 2, 2023 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Bright Green Corporation (NASDAQ: BGXX) resulting from allegations that Bright Green may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Bright Green securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Bright Green Corporation Investors to Inquire About Class Action Investigation - BGXX

NEW YORK , Feb. 24, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Bright Green Corporation (NASDAQ: BGXX) resulting from allegations that Bright Green may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Bright Green securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Bright Green Corporation Investors to Inquire About Class Action Investigation - BGXX

NEW YORK , Feb. 22, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bright Green Corporation ("Bright Green" or the "Company") (NASDAQ: BGXX). Such investors are advised to contact Robert S.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bright Green Corporation - BGXX

NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Bright Green Corporation (“Bright Green” or the “Company”) (NASDAQ: BGXX) on behalf of Bright Green stockholders. Our investigation concerns whether Bright Green has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action.

BRIGHT GREEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Bright Green Corporation on Behalf of Bright Green Stockholders and Encourages Investors to Contact the Firm

NEW YORK , Feb. 16, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Bright Green Corporation (NASDAQ: BGXX) resulting from allegations that Bright Green may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Bright Green securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

BGXX NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Bright Green Corporation Investors to Inquire About Class Action Investigation - BGXX

ATLANTA , Feb. 16, 2023 /PRNewswire/ -- Holzer & Holzer, LLC is investigating whether Bright Green Corporation ("Bright Green" or the "Company") (NASDAQ: BGXX) complied with federal securities laws. On June 2, 2022, Green Market Report published a report detailing Bright Green's history and ongoing litigation against the Company, including a suit brought by the Company's former CEO, who is alleging that Bright Green was "a sham, operated illegally and fraudulently.

SHAREHOLDER ALERT: Investigation of Bright Green Corporation (BGXX) Announced by Holzer & Holzer, LLC

NEW YORK--(BUSINESS WIRE)---- $BGXX #classaction--The law firm of Kirby McInerney LLP is investigating potential claims against Bright Green Corporation (“Bright Green” or the “Company”) (NASDAQ: BGXX). The investigation concerns whether Bright Green and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Bright Green Corporation (BGXX)

NEW YORK--(BUSINESS WIRE)---- $BGXX #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of investors of Bright Green Corporation (“Bright Green” or “the Company”) (NASDAQ: BGXX). Bright Green investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/bgxx. The investigation concerns whether Bright Green violated federal securities laws.

Bronstein, Gewirtz & Grossman, LLC Notifies Bright Green Corporation (BGXX) Investors of Investigation

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Bright Green Corporation (NASDAQ: BGXX) resulting from allegations that Bright Green may have issued materially misleading business information to the investing public.

BGXX INVESTOR NEWS: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Bright Green Corporation Investors to Inquire About Class Action Investigation – BGXX

News reinforces Bright Green's plans to build additional new facilities in Grants, New Mexico, and confirms final requirements and amendments to certificate of occupancy for existing one million square foot greenhouse

Bright Green Announces the Receipt of Its First Funds from Its EB-5 Program

AMTD International Inc

Vallon Pharmaceuticals

Penny stocks to watch with news this week. The post 3 Penny Stocks To Watch After Big News In February 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Penny Stocks To Watch After Big News In February 2023

Terry Rafih to remain as Executive Chairman of the Board

Bright Green Announces Appointment of Seamus McAuley, Chief Operating Officer of Bright Green, as Chief Executive Officer

GRANTS, N.M., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today announced it has begun a review of the trading patterns of the Company's common stock since its listing and will monitor the stock activity going forward. The Company values its shareholders and wants to have all available data at its disposal to act in its fiduciary capacity.

Bright Green Issues Statement of Intent on Illegal Short Selling Activities

Bright Green Corporation (NASDAQ: BGXX) teaches investors the risk and rewards of investing in penny stocks. On February 1, BGXX stock shot up 170% after the company announced plans to raise $500 million as part of the U.S. Citizenship and Immigration Services EB-5 capital program.

Bright Green Corporation Future May be Getting Brighter

One of the more significant moves in today's market belongs to Bright Green (NASDAQ: BGXX ). Shares of the cannabis company have soared on an announced capital raise, with BGXX stock closing Wednesday trading higher by 170%.

Why Did Bright Green (NASDAQ:BGXX) Stock Gain 170% Today?

GRANTS, N.M., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today provided an update on progress on the execution of its business plan and the developments ahead for 2023.

News for Bright Green Corp Stock (BGXX)